Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study
et al., International Journal of Translational Medicine, doi:10.3390/ijtm2020022
Retrospective case series of 240 patients in Italy in 2020, up to 96 years old, showing no mortality and 1.6% hospitalization with early treatment including vitamin C, quercetin, and green tea and red wine polyphenols.The formulation was based on SARS-CoV-2 molecular docking studies. Low bioavailability is a known issue for polyphenols. Authors note that bioavailability may be improved with combinations of polyphenols which may have a synergistic effect, and via consumption with dietary fat.
Ortore et al., 6/16/2022, Italy, peer-reviewed, 12 authors, study period September 2020 - December 2021.
Contact:
eliana.tranchita@gmail.com (corresponding author), ortore.massimiliano@libero.it, alessiamanteca@yahoo.it, sinerfitonlus@gmail.com, iginofabi@libero.it, antonella.foti2010@libero.it, giovanna.borriello@gmail.com, paoloriondino@gmail.com, elisa.grazioli@uniroma4.it, carlo.minganti@uniroma4.it, claudia.cerulli@uniroma4.it, attilio.parisi@uniroma4.it.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.